• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    January AI Raises $8.8 Million in New Funding

    FDA Clears Ava Fertility Tracking Wearable Device

    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Medbio LLC

    FUTEK Advanced Sensor Technology Inc.

    Qosina Corp.

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Spectrum Plastics Group

    Creganna Medical, part of TE Connectivity

    Forefront Medical Technology

    FUTEK Advanced Sensor Technology Inc.

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

    The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle.

    Related CONTENT
    • Refurbished Medical Equipment Testing and Certification Under the NEC
    • Japan to Lead APAC Assisted Reproductive Technology Devices Market
    • Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    • FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump
    • Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences
    Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc.11.04.20
    The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle. A priority for Congress is passing additional funding for COVID-19 relief to aid businesses, the healthcare industry, and individuals in dealing with the impact of the pandemic. Furthermore, recent regulatory developments highlight approvals by the Centers for Medicare and Medicaid Services (CMS) for New Technology Add-On Payments (NTAP) for Breakthrough Devices.

    State of Additional COVID-19 Relief
    Since the start of the COVID-19 public health emergency (PHE), Congress has passed four pieces of legislation to provide relief to businesses, healthcare providers, and individuals impacted by the pandemic.

    On March 6, President Trump signed into law H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act (PL: 116-123), Congress’s first legislative action on the coronavirus. On March 18, President Trump signed into law H.R. 6201, the Families First Coronavirus Response Act (PL: 116-127), Congress’s second round of supplemental funding to fight the coronavirus outbreak. And on March 27, President Trump signed into law H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act (PL: 116-136). The $2 trillion CARES Act provides financial support to individuals and businesses affected by the virus, hospitals and healthcare workers, and local communities, as well as funding to develop vaccines and treatments. The fourth piece of legislation, H.R. 266, the Paycheck Protection Program and Health Care Enhancement Act (PL: 116-139), was signed into law on April 24. The $484 billion bill provides supplemental funding to several programs established under the CARES Act.

    The bill increases federal funding to small businesses impacted by COVID-19, providers, and hospitals; it also includes funding to assist state and local governments’ testing capabilities. Specifically, the bill allocates $75 billion to hospitals and healthcare providers to support COVID-19 treatment costs and lost revenues. This funding is in addition to the $100 billion issued to providers under the CARES Act.

    Since passage of the Paycheck Protection Program and Health Care Enhancement Act in April, House Democrats, Senate Republicans, and the White House have engaged in a number of discussions on further COVID-19 relief. Several pieces of legislation have been proposed; however, House Speaker Nancy Pelosi (D-CA), Senate Majority Leader Mitch McConnell (R-KY), and Treasury Secretary Steven Mnuchin have been unable to reach an agreement over the course of nearly six months.

    On May 15, the House passed H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, in a 208-199 vote, mostly on party lines. The package, which totals over $3 trillion, is House Democrats’ additional legislative proposal to combat the COVID-19 crisis. The package includes funding for state and local governments, healthcare providers, payments to individuals, and further assistance to families in need. Specifically, the bill includes an additional $100 billion for healthcare providers to cover COVID-19- related expenses and lost revenue. McConnell has since refused to take up the bill in the Senate, instead offering his own substantially smaller COVID-19 relief package, the HEALS Act.

    On July 27, Senate Republicans introduced the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, a $1 trillion legislative package to provide relief to businesses, workers, healthcare providers, and individuals impacted by the COVID-19 pandemic. The package, which serves as Senate Republicans starting point in negotiations for additional COVID-19 relief, contains liability protections for businesses and employers, a second round of $1,200 payments to individuals earning up to $75,000 and $2,400 for couples earning up to $150,000, and extends enhanced unemployment benefits contained in the CARES Act, while lowering the $600 per week to $200 per week. The bill also provides the U.S. Department of Health and Human Services with $118.4 billion, including $51 billion for COVID-19 testing and vaccine development, and allocates an additional $25 billion to the Provider Relief Fund. Under the bill, providers would have until Jan. 1, 2021, to pay back Medicare Accelerated and Advance payment loans. Further, the bill extends Medicare telehealth waivers through either the length of the public health emergency or Dec. 31, 2021, and provides an additional $190 billion to the Paycheck Protection Program (PPP), allowing entities with less than 300 employees to take out a second PPP loan.

    On Sept. 8, McConnell unveiled a narrower $500 billion COVID-19 relief package. The bill includes $300 billion to bolster weekly unemployment benefits through Dec. 27, and includes another round of loans under the PPP for small businesses. The bill also includes $16 billion for COVID-19 testing and $31 billion for the development of therapeutics and vaccines. Among the larger items not addressed in the bill are assistance to state and local authorities and additional funding for the Provider Relief Fund. On Sept. 10, the bill failed to advance the Senate in a 52-47 vote, needing 60 votes to clear procedural hurdles.

    On Sept. 15, the House Problem Solvers Caucus, a bipartisan group of moderate lawmakers from purple districts, unveiled a $1.52 trillion COVID-19 relief package in an effort to reach a compromise between Democrats and the White House. The package includes $500 billion to state and local governments, $450 per week in enhanced unemployment benefits, stimulus checks to individuals, and an extension of PPP loans for small businesses. The bill also extends liability protections for businesses and employers, and includes $30 billion to support healthcare providers and $45 billion in forgiveness of Medicare loans to providers. Notably, Pelosi did not offer support for the package, stating her intent to hold out for something with a much larger price tag. President Donald Trump had signaled openness to the Problem Solvers proposal, calling on Senate Republicans to support a larger sized package.

    On Oct. 1, the House passed H.R. 925, the Heroes Act, on a 214-207 vote. The $2.2 trillion bill, which is a smaller version of the HEROES Act, includes another round of $1,200 stimulus checks to individuals, $600 per week in enhanced unemployment benefits, $436 billion to state and local governments, and allows the hardest hit small businesses to apply for additional PPP loans. The bill also includes $75 billion for coronavirus testing and contact tracing and provides $20 billion to the Biomedical Advanced Research and Development Authority (BARDA) for the development and procurement of vaccines and therapeutics. McConnell has since indicated he would not take up the bill in the Senate.

    As of the time of writing, Congress is still working on the details of an additional COVID-19 relief package, as negotiations between the House, Senate, and White House continue. These efforts have been sidelined by campaigning and the political dynamics surrounding the elections on Nov. 3, in addition to commentary from the president. On Oct. 6, President Trump abruptly directed his representatives in the White House to stop negotiating with House Democrats on an additional COVID-19 relief package until after the election, during the lame-duck session. However, in an about-face on Oct. 8, the President called on Congress to pass a large COVID-19 relief package. Before the election, Senate Republicans plan to examine another relief package, however, as of this writing, a clear path to its passage is unclear.

    Members of both parties agree more needs to be done, but there are substantial differences on the timing and substance of such legislative action. There is now the expectation that Congress will examine additional COVID-19 relief during the lame-duck session, which lasts from Nov. 3 to the start of the new Congress on Jan. 3, 2021.

    Regulatory Updates
    This summer, CMS devoted much of its energy to drafting and releasing a number of proposed rules related to the Medicare program, including payment rules for both the inpatient and outpatient settings, the Medicare physician fee schedule proposed rule, and the Medicare Coverage of Innovative Technology proposed rule designed to provide faster access to new, innovative medical devices that have been designated as “breakthrough” by the U.S. Food and Drug Administration (FDA) and have also received market authorization. Now is the time to start watching for the release of the final versions of these rules.

    The first of these final rules was issued on Sept. 2 with the release of the “Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Final Policy Changes and Fiscal Year 2021 Rates” (IPPS) Final rule, which updates the national standardized amount for inpatient hospital operating costs for FY 2021. Among other provisions, the 2021 IPPS approved 13 technologies that applied for new technology add-on payments for FY 2021, including two technologies under the alternative pathway for new medical devices that are part of the FDA Breakthrough Devices Program (BDP).

    The BDP was established in 2016 and is a voluntary program for certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. Per the FDA, the goal of the BDP is to “provide patients and health care providers with timely access to these medical devices by speeding up their development, assessment, and review, while preserving the statutory standards for premarket approval, 510(k) clearance, and De Novo marketing authorization, consistent with the Agency’s mission to protect and promote public health.”

    To obtain a breakthrough device designation, the device must meet a set of multipronged criteria. First, the device must provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating disease or conditions. Second, a device must either represent a breakthrough technology, have no approved or cleared alternatives, offer significant advantages over existing approved or cleared alternatives, or be determined that its availability is in the best interest of patients. To date, the FDA has granted nearly 300 breakthrough device designations.

    FY 2021 is the first year for which CMS received applications under the alternative new technology add-on payment model for breakthrough devices—a process CMS finalized in the FY 2020 IPPS rule. In creating the pathway, CMS stated, “[t]his will provide additional Medicare payment for these technologies while real-world evidence is emerging, giving Medicare beneficiaries timely access to the latest innovations in treatment.” It will be interesting to see how many additional devices take advantage of this new pathway in years to come. 


    Jeffrey J. Kimbell, president and founder of Jeffrey J. Kimbell & Associates Inc., represents 45 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the firm provides strategic solutions to clients seeking creation, modification, or proper implementation of public law.

    Eric P. Juhl is a senior director of health policy and reimbursement strategy at Jeffrey J. Kimbell & Associates Inc.

    David C. Rudloff is a senior manager of government affairs at Jeffrey J. Kimbell & Associates Inc. 
    Suggested For You
    Refurbished Medical Equipment Testing and Certification Under the NEC Refurbished Medical Equipment Testing and Certification Under the NEC
    Japan to Lead APAC Assisted Reproductive Technology Devices Market Japan to Lead APAC Assisted Reproductive Technology Devices Market
    Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump
    Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences
    Millstone Medical Outsourcing Reaches 600-Employee Milestone Millstone Medical Outsourcing Reaches 600-Employee Milestone
    FDA Approves Daytime Treatment for Sleep Apnea and Snoring FDA Approves Daytime Treatment for Sleep Apnea and Snoring
    Apple iPhone 12 Magnet Can Deactivate Implantable Cardiac Devices Apple iPhone 12 Magnet Can Deactivate Implantable Cardiac Devices
    Masimo Releases softFlow High-Flow Nasal Cannula Therapy in U.S. Masimo Releases softFlow High-Flow Nasal Cannula Therapy in U.S.
    SteriPack Acquires HS Design SteriPack Acquires HS Design
    Rice University Researchers Receive Funding to Develop Covid-19 Sensor System Rice University Researchers Receive Funding to Develop Covid-19 Sensor System
    BD Collaborates with Scanwell Health BD Collaborates with Scanwell Health
    Investment Advisor Joins Ra Medical Investment Advisor Joins Ra Medical's Board
    Navient Receives Chinese Regulatory Clearance for ENT Applications Navient Receives Chinese Regulatory Clearance for ENT Applications
    Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020 Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020

    Related Columns

    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.03.21


    • Materials
      Three Major Innovation Opportunities for Biomedical Textiles

      Three Major Innovation Opportunities for Biomedical Textiles

      Biomedical textiles are gaining significant momentum for use in medical devices to facilitate less invasive surgical procedures.
      John Greco, Vice President of Sales, Cortland Biomedical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • How to Better Prepare for Regulatory Requests and Minimize Impact

      How to Better Prepare for Regulatory Requests and Minimize Impact

      Pressure to increase efficiency in medical device development has been prevalent over the past year, especially with the intensified regulatory expectations.
      Sandi Schaible, Sherry Parker and Kim Ehman, WuXi AppTec Medical Device Testing 02.03.21


    • C-Suite Challenges in Medtech’s New Normal

      C-Suite Challenges in Medtech’s New Normal

      Many of the usual C-Suite management topics that are key to organizational success will remain the same this year.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 02.03.21

    • COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      By the time COVID-19 arrived in the United States, global supply chains were already buckling under a historic level of demand.
      Denise Odenkirk, Vice President, Supplier Sales, Global Healthcare Exchange LLC 02.03.21

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20


    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20

    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20


    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20

    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • TransEnterix Changes Name To Asensus Surgical
    • An Analysis Of The Smart Inhalers Market
    Breaking News
    • January AI Raises $8.8 Million in New Funding
    • FDA Clears Ava Fertility Tracking Wearable Device
    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    • Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    • Japan to Lead APAC Assisted Reproductive Technology Devices Market
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login